Hygeia Healthcare (HKG:6078) recorded a decline in attributable profit in 2024 to 598.3 million yuan from 682.9 million yuan in the year-ago period, a Thursday filing with the Hong Kong bourse said.
Earnings per share were 0.95 yuan in the year, down from 1.08 yuan in 2023.
Revenue for the oncology healthcare group rose by 9.1% to 4.45 billion yuan in the year from 4.08 billion yuan a year prior.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.